Latest News

Plant closures put Tyson Foods (TSN) cost actions and demand pressures in focus Tyson Foods (TSN) has drawn fresh attention after deciding to shut its Hillshire Brands plant in Rome, Georgia, as part of a broader series of production closures tied to softer meat demand and higher prices. See our latest analysis for Tyson Foods. Shares now trade at US$64.96, with a 30 day share price return of 7.69% and a 1 year total shareholder return of 10.28%. This suggests momentum has been building even...

In April 2026, Daiichi Sankyo and Merck reported that the FDA accepted and granted Priority Review to their Biologics License Application for ifinatamab deruxtecan for adults with extensive-stage small cell lung cancer progressing after platinum-based chemotherapy, with an FDA action date set for October 10, 2026. This Priority Review, alongside Breakthrough Therapy Designation and inclusion in programs like Real-Time Oncology Review and Project Orbis, underscores regulatory momentum for...

Hewlett Packard Enterprise (HPE) has drawn fresh attention after recent share price moves, with the stock showing a roughly 13% gain over the past month and about 11% over the past 3 months. See our latest analysis for Hewlett Packard Enterprise. Set against a 1 year total shareholder return of 67.14% and a 5 year total shareholder return of 79.79%, the recent 13.39% 30 day share price return suggests momentum has been building despite a softer 1 day move. If HPE’s recent move has you...

Earlier this month, Manulife Wealth & Asset Management appointed Brett Marchand as President & CEO of Manulife Wealth, while Erica Hall assumed interim leadership of Canada Retirement, both reporting to Global Head of Retirement and Wealth Aimee DeCamillo after Richard McIntyre’s departure. At the same time, Manulife’s John Hancock division advanced its health-focused agenda by hosting a longevity symposium in Boston and expanding Vitality heart health offerings with discounted at-home...

Wondering if Coupang at around US$20.72 is a bargain or just fairly priced? This article walks through what that number might really mean for you. The stock has returned 8.0% over the last 7 days and 12.3% over the last 30 days, while year to date it is at an 11.3% loss and the 1 year return sits at a 3.5% loss, compared with a 30.6% gain over 3 years and a 51.4% loss over 5 years. Recent headlines around Coupang have focused on its role as a major Korea based e commerce platform and how its...

Enphase Energy (ENPH) has put its commercial microinverter push in the spotlight by expanding shipments of its IQ9N-3P and IQ8P-3P units from U.S. facilities to meet installer demand and evolving regulation. See our latest analysis for Enphase Energy. The recent expansion of U.S.-made commercial microinverters comes after a period of weaker share price returns, with a 30-day share price return showing a 27.39% decline and a 1-year total shareholder return reflecting a 39.70% loss, which...

Recent Performance Snapshot Artisan Partners Asset Management (APAM) has recently drawn attention after a 2.6% move in the latest session, extending its gains over the past week and month while remaining lower across the past 3 months. See our latest analysis for Artisan Partners Asset Management. That recent 1-day share price return of 2.57% and 7-day share price return of 6.59% comes after a weaker patch. The 90-day share price return shows a 12.40% decline, while the 1-year total...

Lazard (LAZ) has drawn fresh attention after reporting preliminary assets under management of about US$259.2b as of March 31, 2026, alongside market and FX depreciation and modest net inflows. See our latest analysis for Lazard. The recent AUM update has arrived alongside a sharp short term rebound, with a 7 day share price return of 21.44% and 1 year total shareholder return of 45.61%. However, the 90 day share price return remains slightly negative, which suggests that momentum has only...

Agilent Technologies (A) is back in focus after two contrasting developments: the Supreme Court left rulings invalidating its CRISPR related patents in place, and the company introduced its new BioTek Cytation 9 cell imaging multimode reader. See our latest analysis for Agilent Technologies. At a share price of $120.39, investors have seen a 7.96% 1 month share price return and a 5.72% 7 day gain. However, the 90 day share price return of 17.50% and year to date share price return of 12.73%...

Datadog (DDOG) has expanded its observability platform with Datadog Experiments, a new tool that lets product teams run A/B tests and measure business impact directly alongside application performance and user behavior data. See our latest analysis for Datadog. Despite product launches like Datadog Experiments and upbeat commentary around AI related demand, the share price has a negative 17.34% year to date return and an 11.20% 1 month share price return. However, the 1 year total shareholder...

CRISPR Therapeutics (NasdaqGM:CRSP) reports accelerating sales momentum and market adoption for its approved gene editing therapy, Casgevy. The company holds nearly US$2b in cash, supporting investment in new programs across cardiovascular disease, cancers, and autoimmune disorders. Six clinical programs are scheduled for readouts over the next 6 to 12 months, marking an expansion beyond rare disease indications. For investors tracking gene editing, CRISPR Therapeutics sits at an important...

As Gulf markets experience a rise, buoyed by hopes of diplomatic breakthroughs and economic resilience, investors are closely monitoring the potential impact of geopolitical developments on regional indices. With Dubai's main share index advancing and other Gulf markets showing gains, the spotlight turns to identifying promising opportunities within this dynamic landscape. In such an environment, a good stock is often characterized by its ability to navigate market fluctuations while...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

As most Gulf markets experience gains amid ongoing US-Iran diplomatic discussions, investors are closely monitoring the potential impacts on regional indices and economic stability. In this context, dividend stocks can offer a reliable income stream, providing a cushion against market fluctuations while capitalizing on the Middle East's evolving economic landscape.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Energy shocks, sticky inflation and shifting central bank policies are keeping markets on edge, but they are also creating room for smaller, more focused companies to stand out. While headlines center on mega caps, some early-stage AI names in machine learning, automation and data intelligence are quietly building tools that could reshape how businesses cope with higher costs and supply disruptions. This article highlights 3 stocks from an AI Small Caps screener that targets these kinds of...

Why Artemis Gold’s steady 2026 guidance matters after Q1 disruption Artemis Gold (TSXV:ARTG) kept full year 2026 production guidance at 265,000 to 290,000 ounces of gold after Q1 disruption, while reporting 61,923 ounces from the Blackwater Mine for the March quarter. See our latest analysis for Artemis Gold. That reassurance appears to have supported sentiment, with a 16.51% year to date share price return and a very large 3 year total shareholder return. This suggests recent momentum has...

In recent days, Fortescue has faced pressure as concerns about a global diesel supply crunch have clashed with its heavy investment in large-scale renewable energy infrastructure in the Pilbara, intended to cut diesel use and support its operations. This tension between short-term fuel market uncertainty and Fortescue’s long-term plan to lower operating costs through renewables highlights how its green transition could reshape future margins and risk exposure. We’ll now examine how...

Investors may be wondering whether Intel's share price still reflects good value after a strong run, or whether the stock has already priced in much of its story. Intel's last close was US$63.81, with returns of 8.2% over 7 days, 39.4% over 30 days, 62.0% year to date, 231.8% over 1 year, and 109.9% over 3 years. This recent performance is front and center for anyone thinking about risk and reward. These moves have come alongside ongoing attention on Intel's role in semiconductors, AI...

Ficus Technology Holdings Limited's (HKG:8107) value has fallen 16% in the last week, but insiders who sold HK$3.0m...

Why First Industrial Realty Trust is on investors’ radar today First Industrial Realty Trust (FR) has drawn attention after recent trading, with investors weighing its current share price of US$61.10 against its recent return profile and underlying industrial real estate fundamentals. For context, this U.S. focused logistics REIT reports annual revenue of US$727.561 million and net income of US$247.297 million. Both figures are tied entirely to its industrial properties across major...

On April 8, 2026, FactSet Research Systems announced that CFO Helen Shan would step down and be succeeded by incoming CFO Joshua Warren, a finance leader with experience across asset management, financial technology and capital markets. At the same time, FactSet raised its fiscal 2026 earnings and revenue guidance, signaling confidence in its operations despite recent leadership changes and broader market uncertainty. Next, we'll examine how the appointment of Joshua Warren as CFO could...

Why Fair Isaac Stock Is Moving Now Fair Isaac (FICO) has come under pressure after a Barclays note reduced its price target, as investors react to ongoing regulatory questions around credit score pricing and broader weakness across software names. See our latest analysis for Fair Isaac. The share price has lost momentum over recent months, with a 30 day share price return of 10.96% and a 90 day share price return of 37.68%. This has contributed to a year to date decline of 38.70% and a 1 year...